Efficacy and Safety of OSE on improvement of stress

Efficacy and Safety of OSE on improvement of stress; A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003725

Enrollment

Registered

2019-04-08

Start date

2019-02-22

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects will be randomized to receive Ocimum Sanctum Leaf Extract(OSE) 500mg or placebo. Subjects will orally self-adminster OSE 500mg or placebo twice, 2 tablets per day for 8 w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) All men and women aged between 20 and 75 years 2) Stress Response Inventory(SRI) score is over 50 and under 115 3) The subjects, who has agreed to participate in this study and signed the Informed consent form prior to the commencement of this study

Exclusion criteria

Exclusion criteria: 1) The subjects, who are hospitalized, medicated, and rehabilitated due to alcohol use, induced disorder, cardiovascular disease, disorder of central nervous system, etc. 2) The subjects, who suffer from or have history of psychical disorder, such as schizophrenia, bipolar disorder, etc. 3) The subjects, who are judged by the tester to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Stress Response Inventory	—

Secondary

Measure	Time frame
Adrenocorticotropic Hormone;Adverse Event	—

Countries

Korea, Republic of

Contacts

Public ContactChul Hwan Kim

Kangbuk Samsung Medical Center

Outcome results